Picture of Palisade Bio logo

PALI — Palisade Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Palisade Bio Provides Corporate Update And Reiterates Guidance

Feb 13 (Reuters) - Palisade Bio Inc  PALI.O :
    * PALISADE BIO PROVIDES CORPORATE UPDATE AND REITERATES
GUIDANCE
    * STRATEGIC STREAMLINING OF BOARD
    * DONALD WILLIAMS HAS BEEN APPOINTED AS COMPANY'S CHAIRMAN
OF
BOARD
    * CONTINUES TO ADVANCE PALI-2108 FOR TREATMENT OF
MODERATE-TO-SEVERE ULCERATIVE COLITIS (UC) TOWARD A PHASE 1
CLINICAL STUDY
    * DIRECTORS STEPHANIE DIAZ, CRISTINA CSIMMA, PHARMD, MHP,
ROBERT
TRENSCHEL, DO AND JAMES NEAL, CHAIRMAN OF BOARD, RESIGNED FROM
CO'S BOARD
    * DIRECTORS STEPHANIE DIAZ, CRISTINA CSIMMA, ROBERT
TRENSCHEL, AND
JAMES NEAL, CHAIRMAN OF BOARD, RESIGNED FROM CO'S BOARD

Source text for Eikon:  ID:nGNX1rfgKc 
Further company coverage:  PALI.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Palisade Bio

See all news